
Earendil Labs is an AI-powered biotechnology company advancing next-generation biologics for patients with autoimmune diseases, cancer, and other areas of significant unmet medical need. By integrating artificial intelligence across the full R&D life cycle, Earendil Labs and its affiliate Helixon Therapeutics have been building a scalable engine to systematically generate and advance high-quality therapeutic programs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/20/26 | $787,000,000 |
Biotech Development Fund Dimension Capital DST Global INCE Capital Luminous Ventures Miracle Capital Sanofi Ventures | undisclosed |